EE393 The Cost-Effectiveness of Atidarsagene Autotemcel (Arsa-Cel) for the Treatment of Metachromatic Leukodystrophy (MLD) in the US
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.659
https://www.valueinhealthjournal.com/article/S1098-3015(23)03789-0/fulltext
Section Title :
Section Order :
10145
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03789-0&doi=10.1016/j.jval.2023.09.659